{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:14:32Z","timestamp":1793726072838,"version":"4.6.1"},"reference-count":109,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ccl.2019.04.001","type":"journal-article","created":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T10:58:11Z","timestamp":1558436291000},"page":"251-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":135,"title":["Cardiorenal Syndrome"],"prefix":"10.1016","volume":"37","author":[{"given":"Ujjala","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Wettersten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav S.","family":"Garimella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ccl.2019.04.001_bib2","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/ndt\/gfq136","article-title":"Definition and classification of cardio-renal syndromes: workgroup statements from the 7th ADQI consensus conference","volume":"25","author":"House","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.ccl.2019.04.001_bib3","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehp507","article-title":"Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative","volume":"31","author":"Ronco","year":"2009","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ccl.2019.04.001_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2215\/CJN.00730805","article-title":"Kidney-heart interactions: epidemiology, pathogenesis, and treatment","volume":"1","author":"Berl","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.ccl.2019.04.001_bib5","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00134-008-1017-8","article-title":"Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong","volume":"34","author":"Ronco","year":"2008","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ccl.2019.04.001_bib6","volume":"87","year":"2017"},{"issue":"48","key":"10.1016\/j.ccl.2019.04.001_bib7","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1093\/eurheartj\/ehu320","article-title":"Terminology and definition of changes renal function in heart failure","volume":"35","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ccl.2019.04.001_bib8","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"issue":"3","key":"10.1016\/j.ccl.2019.04.001_bib9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000316038","article-title":"Worsening renal function defined as an absolute increase in serum creatinine is a biased metric for the study of cardio-renal interactions","volume":"116","author":"Testani","year":"2010","journal-title":"Cardiology"},{"issue":"11","key":"10.1016\/j.ccl.2019.04.001_bib10","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/eurheartj\/ehs444","article-title":"Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial","volume":"34","author":"Ambrosy","year":"2013","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ccl.2019.04.001_bib11","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/CIRCHEARTFAILURE.114.001957","volume":"8","author":"Lala","year":"2015","journal-title":"Circ Heart Fail"},{"issue":"8","key":"10.1016\/j.ccl.2019.04.001_bib12","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF registry","volume":"50","author":"Fonarow","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2019.04.001_bib13","first-page":"1","article-title":"Kidney Disease: improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Levin","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"9689","key":"10.1016\/j.ccl.2019.04.001_bib14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0140-6736(09)61378-7","article-title":"Albuminuria in chronic heart failure: prevalence and prognostic importance","volume":"374","author":"Jackson","year":"2009","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ccl.2019.04.001_bib15","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1681\/ASN.2008121270","article-title":"Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes","volume":"20","author":"Ninomiya","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.ccl.2019.04.001_bib16","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1093\/aje\/kwn033","article-title":"Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population","volume":"167","author":"Astor","year":"2008","journal-title":"Am\u00a0J Epidemiol"},{"issue":"6","key":"10.1016\/j.ccl.2019.04.001_bib17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cardfail.2007.03.011","article-title":"High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database","volume":"13","author":"Heywood","year":"2007","journal-title":"J\u00a0Card Fail"},{"issue":"7","key":"10.1016\/j.ccl.2019.04.001_bib18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ccl.2019.04.001_bib19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/CIRCHEARTFAILURE.111.963413","article-title":"Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function","volume":"5","author":"Metra","year":"2012","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.ccl.2019.04.001_bib20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1681\/ASN.2005030270","article-title":"Kidney function and mortality among patients with left ventricular systolic dysfunction","volume":"17","author":"Khan","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.ccl.2019.04.001_bib21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1161\/CIRCHEARTFAILURE.111.963256","article-title":"Prognostic importance of early worsening renal function following initiation of angiotensin converting enzyme inhibitor therapy in patients with cardiac dysfunction","volume":"4","author":"Testani","year":"2011","journal-title":"Circ Heart Fail"},{"issue":"12","key":"10.1016\/j.ccl.2019.04.001_bib22","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.cardfail.2011.08.009","article-title":"Clinical characteristics and outcomes of patients with improvement in renal function during the treatment of decompensated heart failure","volume":"17","author":"Testani","year":"2011","journal-title":"J\u00a0Card Fail"},{"issue":"10","key":"10.1016\/j.ccl.2019.04.001_bib23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cardfail.2016.06.423","article-title":"Relevance of changes in serum creatinine during a heart failure trial of decongestive strategies: insights from the DOSE trial","volume":"22","author":"Brisco","year":"2016","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.ccl.2019.04.001_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000349966","article-title":"Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI)","volume":"182","author":"McCullough","year":"2013","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.ccl.2019.04.001_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000349968","article-title":"Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI)","volume":"182","author":"Cruz","year":"2013","journal-title":"Contrib Nephrol"},{"issue":"19","key":"10.1016\/j.ccl.2019.04.001_bib26","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1161\/CIRCULATIONAHA.117.030112","article-title":"Worsening renal function in patients with acute heart failure undergoing aggressive diuresis is not associated with tubular injury","volume":"137","author":"Ahmad","year":"2018","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.ccl.2019.04.001_bib27","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.ccl.2019.04.001_bib28","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1007\/s00134-006-0349-5","article-title":"Results from the international conference of experts on intra-abdominal hypertension and abdominal compartment syndrome. I. Definitions","volume":"32","author":"Malbrain","year":"2006","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.ccl.2019.04.001_bib29","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1172\/JCI101867","article-title":"The effect of increased intra-abdominal pressure on renal function in man 1","volume":"26","author":"Bradley","year":"1947","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.ccl.2019.04.001_bib30","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00134-007-0969-4","article-title":"Intra-abdominal hypertension and acute renal failure in critically ill patients","volume":"34","author":"Dalfino","year":"2008","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.ccl.2019.04.001_bib31","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2007.09.043","article-title":"Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function?","volume":"51","author":"Mullens","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ccl.2019.04.001_bib32","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jacc.2008.08.080","article-title":"Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease","volume":"53","author":"Damman","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ccl.2019.04.001_bib33","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","article-title":"Importance of venous congestion for worsening of renal function in advanced decompensated heart failure","volume":"53","author":"Mullens","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ccl.2019.04.001_bib34","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.cardfail.2008.07.236","article-title":"Tricuspid regurgitation contributes to renal dysfunction in patients with heart failure","volume":"14","author":"Maeder","year":"2008","journal-title":"J\u00a0Card Fail"},{"issue":"1","key":"10.1016\/j.ccl.2019.04.001_bib35","first-page":"H98","article-title":"Cardiorenal hemodynamics and sodium excretion in rats with myocardial infarction","volume":"245","author":"Hostetter","year":"1983","journal-title":"Am J Physiol"},{"issue":"13","key":"10.1016\/j.ccl.2019.04.001_bib36","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/jama.294.13.1625","article-title":"Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial","volume":"294","author":"Binanay","year":"2005","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ccl.2019.04.001_bib37","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ejhf.958","article-title":"Acute kidney injury in cardiogenic shock: definitions, incidence, haemodynamic alterations, and mortality","volume":"20","author":"Tarvasm\u00e4ki","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"9248","key":"10.1016\/j.ccl.2019.04.001_bib38","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0140-6736(00)03495-4","article-title":"Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group","volume":"356","author":"Bellomo","year":"2000","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ccl.2019.04.001_bib39","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/sj.ki.5000310","article-title":"\u2018Low-dose\u2019 dopamine worsens renal perfusion in patients with acute renal failure","volume":"69","author":"Lauschke","year":"2006","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ccl.2019.04.001_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.amjcard.2006.01.059","article-title":"Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease","volume":"98","author":"Ferrario","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccl.2019.04.001_bib41","series-title":"Neural control of renin secretion rate","author":"Kopp","year":"2011"},{"issue":"4","key":"10.1016\/j.ccl.2019.04.001_bib42","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1152\/advan.00049.2009","article-title":"The renal renin-angiotensin system","volume":"33","author":"Harrison-Bernard","year":"2009","journal-title":"Adv Physiol Educ"},{"issue":"4","key":"10.1016\/j.ccl.2019.04.001_bib43","first-page":"F298","article-title":"Stimulation of renal sodium reabsorption by angiotensin II","volume":"232","author":"Johnson","year":"1977","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1016\/j.ccl.2019.04.001_bib44","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1006\/bbrc.1997.7394","article-title":"Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in\u00a0vivo: role of ETA receptors for endothelin regulation","volume":"238","author":"Barton","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"issue":"s3","key":"10.1016\/j.ccl.2019.04.001_bib45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2362.2006.01689.x","article-title":"Role of endothelin and endothelin receptor antagonists in renal disease","volume":"36","author":"Neuhofer","year":"2006","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"10.1016\/j.ccl.2019.04.001_bib46","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0008-6363(98)00121-7","article-title":"Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-\u03b21 and endothelin-1 from fibroblasts","volume":"40","author":"Gray","year":"1998","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.ccl.2019.04.001_bib47","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/HCO.0b013e3281532b53","article-title":"Angiotensin II and oxidative stress","volume":"22","author":"Hitomi","year":"2007","journal-title":"Curr Opin Cardiol"},{"issue":"19","key":"10.1016\/j.ccl.2019.04.001_bib48","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2009.05.015","article-title":"The sympathetic nervous system in heart failure: physiology, pathophysiology, and clinical implications","volume":"54","author":"Triposkiadis","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ccl.2019.04.001_bib49","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/01.CIR.95.6.1363","article-title":"Plasma adenosine levels increase in patients with chronic heart failure","volume":"95","author":"Funaya","year":"1997","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.ccl.2019.04.001_bib50","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa0912613","article-title":"Rolofylline, an adenosine A1\u2212Receptor antagonist, in acute heart failure","volume":"363","author":"Massie","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.ccl.2019.04.001_bib51","doi-asserted-by":"crossref","first-page":"10397","DOI":"10.1073\/pnas.96.18.10397","article-title":"Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: study in vasopressin-deficient Brattleboro rats","volume":"96","author":"Bardoux","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.ccl.2019.04.001_bib52","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/ki.2009.325","article-title":"Vasopressin in chronic kidney disease, an elephant in the room?","volume":"76","author":"Torres","year":"2009","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.ccl.2019.04.001_bib53","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.CIR.82.5.1724","article-title":"Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)","volume":"82","author":"Francis","year":"1990","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ccl.2019.04.001_bib54","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0735-1097(94)90001-9","article-title":"Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril","volume":"24","author":"Rouleau","year":"1994","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ccl.2019.04.001_bib55","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1113\/expphysiol.1997.sp004024","article-title":"Oxidative stress: oxidants and antioxidants","volume":"82","author":"Sies","year":"1997","journal-title":"Exp Physiol"},{"issue":"6","key":"10.1016\/j.ccl.2019.04.001_bib56","doi-asserted-by":"crossref","first-page":"L1005","DOI":"10.1152\/ajplung.2000.279.6.L1005","article-title":"Reactive oxygen species in cell signaling","volume":"279","author":"Thannickal","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"10.1016\/j.ccl.2019.04.001_bib57","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11897-015-0254-8","article-title":"Venous congestion, endothelial and neurohormonal activation in acute decompensated heart failure: cause or effect?","volume":"12","author":"Colombo","year":"2015","journal-title":"Curr Heart Fail Rep"},{"issue":"11","key":"10.1016\/j.ccl.2019.04.001_bib58","doi-asserted-by":"crossref","first-page":"23011","DOI":"10.3390\/ijms141123011","article-title":"Pathogenesis of chronic cardiorenal syndrome: is there a role for oxidative stress?","volume":"14","author":"Rubattu","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ccl.2019.04.001_bib59","series-title":"Heart failure: pathophysiology, molecular biology, and clinical management","author":"Katz","year":"2012"},{"key":"10.1016\/j.ccl.2019.04.001_bib60","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/391790","article-title":"Oxidative stress: dual pathway induction in cardiorenal syndrome type 1 pathogenesis","volume":"2015","author":"Virz\u00ec","year":"2015","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"10.1016\/j.ccl.2019.04.001_bib61","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/01.HYP.0000163462.98381.7f","article-title":"Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II","volume":"45","author":"Kimura","year":"2005","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.ccl.2019.04.001_bib62","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0022-2828(03)00145-7","article-title":"NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy","volume":"35","author":"Nakagami","year":"2003","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2019.04.001_bib63","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1152\/ajpregu.00476.2002","article-title":"Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression","volume":"285","author":"Chabrashvili","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"38","key":"10.1016\/j.ccl.2019.04.001_bib64","doi-asserted-by":"crossref","first-page":"23317","DOI":"10.1074\/jbc.271.38.23317","article-title":"P22phox is a critical component of the superoxide-generating NADH\/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells","volume":"271","author":"Ushio-Fukai","year":"1996","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ccl.2019.04.001_bib65","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/1471-2164-10-388","article-title":"Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease","volume":"10","author":"Granata","year":"2009","journal-title":"BMC Genomics"},{"issue":"3","key":"10.1016\/j.ccl.2019.04.001_bib66","first-page":"15","article-title":"Oxidative stress in chronic kidney disease","volume":"9","author":"Modaresi","year":"2015"},{"issue":"3","key":"10.1016\/j.ccl.2019.04.001_bib67","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.V83475","article-title":"Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors","volume":"8","author":"Becker","year":"1997","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.ccl.2019.04.001_bib68","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/ki.1990.44","article-title":"Interleukin 1-alpha and tumor necrosis factor-alpha induce oxygen radical production in mesangial cells","volume":"37","author":"Radeke","year":"1990","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.ccl.2019.04.001_bib69","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0735-1097(97)00494-4","article-title":"Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure","volume":"31","author":"Tsutamoto","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ccl.2019.04.001_bib70","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.amjmed.2016.01.013","article-title":"Biomarkers for heart failure: an update for practitioners of internal medicine","volume":"129","author":"Wettersten","year":"2016","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.ccl.2019.04.001_bib71","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ki.2009.503","article-title":"Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease","volume":"77","author":"Barreto","year":"2010","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.ccl.2019.04.001_bib72","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1523-1755.2005.00200.x","article-title":"IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly","volume":"67","author":"Stenvinkel","year":"2005","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.ccl.2019.04.001_bib73","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/ki.1994.117","article-title":"Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients","volume":"45","author":"Pereira","year":"1994","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.ccl.2019.04.001_bib74","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1161\/01.ATV.18.9.1386","article-title":"C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries","volume":"18","author":"Torzewski","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.ccl.2019.04.001_bib75","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1523-1755.2001.059002407.x","article-title":"End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?","volume":"59","author":"Arici","year":"2001","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.ccl.2019.04.001_bib76","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1182\/blood.V82.2.513.513","article-title":"C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor","volume":"82","author":"Cermak","year":"1993","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.ccl.2019.04.001_bib77","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.amjcard.2017.12.046","article-title":"Effect of elevated C-reactive protein level at discharge on long-term outcome in patients hospitalized for acute heart failure","volume":"121","author":"Minami","year":"2018","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ccl.2019.04.001_bib78","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000085585","article-title":"Persistent elevation of C-reactive protein may predict cardiac hypertrophy and dysfunction in patients maintained on hemodialysis","volume":"25","author":"Kim","year":"2005","journal-title":"Am J Nephrol"},{"issue":"3","key":"10.1016\/j.ccl.2019.04.001_bib79","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0272-6386(00)70200-9","article-title":"C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients","volume":"35","author":"Yeun","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1016\/j.ccl.2019.04.001_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10120520","article-title":"Association between protein-bound uremic toxins and asymptomatic cardiac dysfunction in patients with chronic\u00a0kidney disease","volume":"10","author":"Chinnappa","year":"2018","journal-title":"Toxins (Basel)"},{"issue":"9","key":"10.1016\/j.ccl.2019.04.001_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10090352","article-title":"Cardiotoxicity of uremic toxins: a driver of cardiorenal syndrome","volume":"10","author":"Lekawanvijit","year":"2018","journal-title":"Toxins (Basel)"},{"issue":"6","key":"10.1016\/j.ccl.2019.04.001_bib82","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.arcmed.2012.08.002","article-title":"Indoxyl sulfate predicts cardiovascular disease and renal function deterioration in advanced chronic kidney disease","volume":"43","author":"Lin","year":"2012","journal-title":"Arch Med Res"},{"issue":"7","key":"10.1016\/j.ccl.2019.04.001_bib83","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1097\/01.ASN.0000022017.96399.B2","article-title":"Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity","volume":"13","author":"Enomoto","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.ccl.2019.04.001_bib84","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1523-1755.2004.00399.x","article-title":"The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair","volume":"65","author":"Dou","year":"2004","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.ccl.2019.04.001_bib85","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/ndt\/gfq580","article-title":"p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease","volume":"26","author":"Wu","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.ccl.2019.04.001_bib86","article-title":"p-Cresyl sulfate aggravates cardiac dysfunction associated with chronic kidney disease by enhancing apoptosis of cardiomyocytes","volume":"4","author":"Han","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.ccl.2019.04.001_bib87","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1159\/000112823","article-title":"Indoxyl sulfate reduces superoxide scavenging activity in the kidneys of normal and uremic rats","volume":"28","author":"Owada","year":"2008","journal-title":"Am J Nephrol"},{"issue":"7","key":"10.1016\/j.ccl.2019.04.001_bib88","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/ndt\/gfp007","article-title":"Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress","volume":"24","author":"Fujii","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"Pt 18","key":"10.1016\/j.ccl.2019.04.001_bib89","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1113\/jphysiol.2014.273078","article-title":"Cardiorenal syndrome: acute kidney injury secondary to cardiovascular disease and role of protein-bound uraemic toxins","volume":"592","author":"Lekawanvijit","year":"2014","journal-title":"J\u00a0Physiol"},{"issue":"10","key":"10.1016\/j.ccl.2019.04.001_bib90","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.ccl.2019.04.001_bib91","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J\u00a0Clin Invest"},{"issue":"8","key":"10.1016\/j.ccl.2019.04.001_bib92","doi-asserted-by":"crossref","first-page":"E863","DOI":"10.1152\/ajpendo.00596.2012","article-title":"FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy","volume":"304","author":"Touchberry","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ccl.2019.04.001_bib93","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/eci.12296","article-title":"FGF-23 dysregulates calcium homeostasis and electrophysiological properties in HL-1 atrial cells","volume":"44","author":"Kao","year":"2014","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"10.1016\/j.ccl.2019.04.001_bib94","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/01.CIR.0000052622.51963.FC","article-title":"Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure","volume":"107","author":"Ezekowitz","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ccl.2019.04.001_bib95","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10741-011-9230-x","article-title":"Anemia in Cardio-Renal Syndrome: clinical impact and pathophysiologic mechanisms","volume":"16","author":"Palazzuoli","year":"2011","journal-title":"Heart Fail Rev"},{"issue":"5","key":"10.1016\/j.ccl.2019.04.001_bib96","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.ahj.2009.01.012","article-title":"Prospective assessment of the occurrence of anemia in patients with heart failure: results from the study of anemia in a heart failure population (STAMINA-HFP) registry","volume":"157","author":"Adams","year":"2009","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.ccl.2019.04.001_bib97","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.amjcard.2007.07.067","article-title":"Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry)","volume":"101","author":"Young","year":"2008","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.ccl.2019.04.001_bib98","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1185\/030079904X2763","article-title":"The prevalence of anemia in patients with chronic kidney disease","volume":"20","author":"McClellan","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ccl.2019.04.001_bib99","first-page":"S11","article-title":"KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease","volume":"47","author":"American Journal of Kidney Diseases","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"1 Suppl","key":"10.1016\/j.ccl.2019.04.001_bib100","first-page":"S18","article-title":"Oxidative stress in anemia","volume":"53","author":"Grune","year":"2000","journal-title":"Clin Nephrol"},{"issue":"10","key":"10.1016\/j.ccl.2019.04.001_bib101","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJM199503093321006","article-title":"Hypoxia of the renal medulla \u2014 its implications for disease","volume":"332","author":"Brezis","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccl.2019.04.001_bib102","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1681\/ASN.V13127","article-title":"Preglomerular and postglomerular resistance responses to different levels of sympathetic activation by hypoxia","volume":"13","author":"Denton","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"20","key":"10.1016\/j.ccl.2019.04.001_bib103","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.ccl.2019.04.001_bib104","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"Normalization of hemoglobin level in patients with chronic kidney disease and anemia","volume":"355","author":"Dr\u00fceke","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.ccl.2019.04.001_bib105","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A\u00a0trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.ccl.2019.04.001_bib106","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa1214865","article-title":"Treatment of anemia with darbepoetin alfa in systolic heart failure","volume":"368","author":"Swedberg","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2019.04.001_bib107","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000329243","article-title":"Pathophysiology of sepsis-induced acute kidney injury: the role of global renal blood flow and renal vascular resistance","volume":"174","author":"Bougl\u00e9","year":"2011","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.ccl.2019.04.001_bib108","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000349970","article-title":"Cardiorenal syndrome type 5: clinical presentation, pathophysiology and management strategies from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI)","volume":"182","author":"Mehta","year":"2013","journal-title":"Contrib Nephrol"},{"issue":"2","key":"10.1016\/j.ccl.2019.04.001_bib109","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ihj.2017.01.005","article-title":"Pathophysiology of the cardio-renal syndromes types 1\u20135: an uptodate","volume":"69","author":"Di Lullo","year":"2017","journal-title":"Indian Heart J"},{"issue":"2","key":"10.1016\/j.ccl.2019.04.001_bib110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrneph.2012.279","article-title":"Cardiorenal syndrome: pathophysiology and potential targets for clinical management","volume":"9","author":"Hatamizadeh","year":"2013","journal-title":"Nat Rev Nephrol"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386511930027X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386511930027X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:51:02Z","timestamp":1760007062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073386511930027X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":109,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S073386511930027X"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2019.04.001","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiorenal Syndrome","name":"articletitle","label":"Article Title"},{"value":"Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccl.2019.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}